Genmab | GEN - Satış Brüt Kar





Satış Brüt Kar Değişiklik Tarih
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Almirall EUR 429.87M 180.02M 2025-12
Amarin USD 23.17M 961K 2025-12
Amgen USD 6.89B 415M 2025-12
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Bayer EUR 6.94B 1.58B 2025-12
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Demant DKK 8.82B 277M 2025-12
Exelixis USD 590.86M 18.68M 2026-03
Fresenius Medical Care EUR 1.18B 210M 2026-03
Genmab DKK 977M 13M 2025-12
GlaxoSmithKline GBP 6.51B 757M 2026-06
GN Store Nord DKK 2.5B 344M 2025-12
GRIFOLS EUR 620M 66.84M 2026-03
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Insmed USD 256.46M 38.78M 2026-03
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.07B 104M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 3.19B 621M 2025-12